Menu Menu

IBRX    Immunitybio Inc    1326110    
Income Statement
Revenue ibrx-20240930 6,106,000
Net Income ibrx-20240930 -85,729,000
Profit Margin -1404.01%

Balance Sheet
Current Assets 163,150,000
Assets 364,570,000
Current Liabilities 60,960,000
Liabilities 1,108,732,000
Equity -744,162,000
Shares Out 696,533,000

Cash Flow Statement
Operating Cash Flow -306,092,000
Investing Cash Flow -22,080,000

Market Analysis
Market Cap 2,284,560,278
Price 2.94
BVPS 2.65
PB 1.11
EPS -0.94
PS 93.54
FCF -328,172,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/19 0.57
Apr May Jun
5/09 -0.20
Jul Aug Sep
8/12 -0.20
Oct Nov Dec
11/12 -0.12

Find a discrepancy? The most accurate way to find company fundamental data is to view IBRX documents filed with the SEC.


IBRX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas